Protea Biosciences Group, Inc. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/60ef36d3-ff31-4d62-bda9-57a3b874e368/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2016 | $-5.5M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-020500 |
| FY 2015 | $-7.1M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-088486 |
| FY 2014 | $-10.7M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-009007 |
| FY 2013 | $-57.9M | 2001-07-13 – 2014-03-31 | evidence 0001144204-14-028814 |
| FY 2012 | $-47.4M | 2001-07-13 – 2013-03-31 | evidence 0001144204-13-027996 |
| FY 2011 | $-38.8M | 2001-06-13 – 2012-03-31 | evidence 0001144204-12-028704 |
| FY 2010 | $-9.3M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-018104 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Protea Biosciences Group, Inc. — all facts · Revenue · Net Income